2593 completed, 686 terminated, 582 recruiting, 464 unknown. 4990 Phase 1, 1634 Phase 2.
Follow Lung Diseases: new trials by email Literature Review of Lung Diseases trials Research Report on Lung Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation RC48-ADC, Pyrotinib - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | RemeGen Co., Ltd. | 26 | 2027-12-01 | 2026-09-22 |
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets MN-08 24 mg/day, MN-08 60 mg/day - Pulmonary Arterial Hypertension | Phase 1 | Not yet recruiting | Guangzhou Magpie Pharmaceuticals Co., Ltd. | 16 | 2027-09-01 | 2026-09-14 |
| cfMSC Stem Cell Therapy Targeting COPD clonal fetal MSCs - Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-30 | 2026-11-02 |
| Antigen-specific T Cells Against Lung Cancer Lung cancer-specific T cells - Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 20 | 2027-06-01 | 2026-11-02 |
| Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab PANDA-VAC, Pembrolizumab - Squamous Cell Lung Cancer, Squamous Non-small Cell Lung Cancer | Phase 1 | Suspended | UNC Lineberger Comprehensive Cancer Center | 6 | 2027-05-20 | 2026-04-23 |
| A Phase 1a/1b Of Zanidatamab In Combination With Zongertinib In HER2-Mutated Non-Small Cell Lung Cancer (NSCLC) Zanidatamab, Zongertinib - Non Small Cell Lung Cancer | Phase 1 | Not yet recruiting | M.D. Anderson Cancer Center | 24 | 2027-04-01 | 2026-10-28 |
| Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI Hyperpolarized xenon MRI - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Not yet recruiting | Xemed LLC | 10 | 2027-03-01 | 2026-09-01 |
| Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations Metformin - Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Not yet recruiting | Duke University | 45 | 2027-02-01 | 2026-11-03 |
| Little Lungs Study Calfactant, Budesonide - Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome | Phase 1 / Phase 2 | Not yet recruiting | University of Wisconsin, Madison | 24 | 2027-02-01 | 2026-11-02 |
| DK222 Study at Hopkins [18F]DK222 radiotracer - Non-Small Cell Lung Cancer, Urothelial Cancer | Phase 1 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 | 2027-01-31 | 2026-09-29 |
| Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection, Cisplatin - Extensive-stage Small-cell Lung Cancer | Phase 1 | Suspended | University of Maryland, Baltimore | 50 | 2027-01-30 | 2026-09-14 |
| A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age Pn-MAPS30plus, PCV20 - Pneumonia, Bacterial | Phase 1 | Not yet recruiting | GlaxoSmithKline | 60 | 2027-01-25 | 2026-07-16 |
| Study Using a Drug-device Combination Product to Determine Safety, Tolerability and Antitumor Activity for Patients With Advanced, Non-small Cell Lung Cancer NHT102, DryNeb - NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 / Phase 2 | Not yet recruiting | Nob Hill Therapeutics, Inc. | 100 | 2027-01-11 | 2026-10-08 |
| Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer Lurbinectedin, Osimertinib - Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Misty Shields | 16 | 2027-01-01 | 2026-10-15 |
| Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms IV infusion using an isolated, placental, mesenchymal stem cell derived EVs, Placebo IV administration - COVID-19 | Phase 1 / Phase 2 | Not yet recruiting | Kimera Labs Inc. | 64 | 2027-01-01 | 2026-06-24 |
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension Protek Solo Transseptal Cannula - Lung Transplant, Pulmonary Hypertension | Phase 1 | Recruiting | Mayo Clinic | 4 | 2026-12-11 | 2026-07-31 |
| Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer Tocilizumab, Pembrolizumab, Platinum-Doublet Chemotherapy - Metastatic Non-Small Cell Lung Cancer, Cancer-Associated Weight Loss | Phase 1 / Phase 2 | Not yet recruiting | VA Office of Research and Development | 43 | 2026-12-07 | 2026-11-12 |
| 3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial 3-Dimensional VR Modelling (Elucis) with Intravascular Indocyanine Green Fluorescence Mapping, 3-Dimensional Modelling (Synapse 3D) with Intravascular Indocyanine Green Fluorescence Mapping - Non Small Cell Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | St. Joseph's Healthcare Hamilton | 89 | 2026-12-01 | 2026-02-02 |
| The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD Inhaled Nitric Oxide, Placebo - Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 80 | 2026-12-01 | 2026-07-08 |
Showing 20 of 4990. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (1978) · Lung Neoplasms (867) · COVID-19 (675) · Colorectal Neoplasms (402) · Asthma (399) · Small Cell Lung Carcinoma (398) · Neoplasms (360) · Pulmonary Disease, Chronic Obstructive (353) · Breast Neoplasms (351) · Melanoma (340) · Ovarian Neoplasms (327) · Pancreatic Neoplasms (268) · Neoplasm Metastasis (259) · Squamous Cell Carcinoma of Head and Neck (255) · Stomach Neoplasms (247)
Respiratory Tract Diseases (4946) · Neoplasms by Site (2686) · Respiratory Tract Neoplasms (2674) · Thoracic Neoplasms (2668) · Neoplasms (2380) · Bronchial Neoplasms (2222) · Carcinoma, Bronchogenic (2221) · Lung Neoplasms (1826) · Neoplasms by Histologic Type (1059) · Digestive System Diseases (1007) · Pathological Conditions, Signs and Symptoms (979) · Infections (931) · Pathologic Processes (918) · Neoplasms, Glandular and Epithelial (868)
pembrolizumab (274) · Carboplatin (236) · Cisplatin (182) · Pemetrexed (162) · Paclitaxel (137) · Nivolumab (134) · Docetaxel (113) · Radiotherapy (107) · Erlotinib Hydrochloride (94) · Gemcitabine (93) · Cyclophosphamide (64) · Etoposide (63) · Bevacizumab (61) · osimertinib (60) · Cetuximab (59)
GlaxoSmithKline (189) · AstraZeneca (121) · National Cancer Institute (NCI) (114) · Pfizer (104) · Novartis Pharmaceuticals (65) · M.D. Anderson Cancer Center (63) · Memorial Sloan Kettering Cancer Center (53) · Boehringer Ingelheim (51) · Merck Sharp & Dohme LLC (48) · Eli Lilly and Company (47) · Bristol-Myers Squibb (37) · Chiesi Farmaceutici S.p.A. (36) · National Institute of Allergy and Infectious Diseases (NIAID) (35) · AbbVie (34) · Amgen (32)
United States (2633) · China (681) · United Kingdom (498) · Spain (380) · Australia (368) · Canada (308) · France (292) · Germany (275) · South Korea (259) · Japan (210) · Belgium (194) · Italy (176) · Taiwan (167) · Netherlands (158) · Poland (98)
PMID 34473343, PMID 33331662, PMID 37983082, PMID 24184147, PMID 35713300, PMID 36435633, PMID 37231296, PMID 22793945, PMID 31215818, PMID 31986264, PMID 33152467, PMID 36147329, PMID 39462179, PMID 40056080, PMID 42820295, PMID 16235359, PMID 16565429, PMID 16636091, PMID 16690673, PMID 17132052, PMID 17507545, PMID 18073405, PMID 19564349, PMID 20549206, PMID 20615924, PMID 21467219, PMID 21975749, PMID 22065672, PMID 22314182, PMID 22473314, PMID 22634621, PMID 22793939, PMID 23032745, PMID 23074435, PMID 23076942, PMID 23235687, PMID 23256721, PMID 23364286, PMID 2337756, PMID 23578144, PMID 23992090, PMID 24508444, PMID 24563632, PMID 24615270, PMID 24739759, PMID 24916507, PMID 25450456, PMID 25747273, PMID 26092545, PMID 26372465
2023 (71), 2016 (50), 2017 (48), 2015 (45), 2019 (38), 2018 (32), 2014 (27), 2025 (25), 2009 (13), 2008 (12), P30CA033572 (11), P30CA093373 (10), UM1CA186717 (8), P30CA138292 (7), P30CA016672 (6)